2013 Q1 Form 10-Q Financial Statement

#000119312513222641 Filed on May 15, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $32.05M $33.32M
YoY Change -3.81% -21.39%
Cost Of Revenue $1.777M $1.961M
YoY Change -9.38% -78.89%
Gross Profit $30.27M $31.36M
YoY Change -3.47% -5.24%
Gross Profit Margin 94.45% 94.11%
Selling, General & Admin $17.86M $18.11M
YoY Change -1.38% -30.24%
% of Gross Profit 59.0% 57.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.022M $1.130M
YoY Change -9.56% -21.53%
% of Gross Profit 3.38% 3.6%
Operating Expenses $22.19M $23.06M
YoY Change -3.77% -28.7%
Operating Profit -$268.0K -$1.054M
YoY Change -74.57% -240.53%
Interest Expense $300.0K $1.071M
YoY Change -71.99% -166.52%
% of Operating Profit
Other Income/Expense, Net $93.00K $0.00
YoY Change
Pretax Income -$568.0K -$2.117M
YoY Change -73.17% 146.16%
Income Tax -$371.0K -$433.0K
% Of Pretax Income
Net Earnings -$186.0K -$1.543M
YoY Change -87.95% 397.74%
Net Earnings / Revenue -0.58% -4.63%
Basic Earnings Per Share -$0.02 -$0.16
Diluted Earnings Per Share -$0.02 -$0.16
COMMON SHARES
Basic Shares Outstanding 9.446M shares 9.448M shares
Diluted Shares Outstanding 9.446M shares 9.448M shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.200M $900.0K
YoY Change 255.56% 12.5%
Cash & Equivalents $2.559M $900.0K
Short-Term Investments
Other Short-Term Assets $10.10M $14.30M
YoY Change -29.37% 6.72%
Inventory $3.842M $4.200M
Prepaid Expenses
Receivables $13.70M $16.70M
Other Receivables $1.100M $500.0K
Total Short-Term Assets $31.95M $36.50M
YoY Change -12.47% -1.62%
LONG-TERM ASSETS
Property, Plant & Equipment $30.48M $30.90M
YoY Change -1.37% -10.69%
Goodwill $461.0K
YoY Change
Intangibles $3.212M
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.721M $11.50M
YoY Change -85.03% 61.97%
Total Long-Term Assets $39.91M $46.30M
YoY Change -13.8% -22.83%
TOTAL ASSETS
Total Short-Term Assets $31.95M $36.50M
Total Long-Term Assets $39.91M $46.30M
Total Assets $71.86M $82.80M
YoY Change -13.21% -14.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.409M $7.600M
YoY Change -15.67% -7.32%
Accrued Expenses $6.500M $7.800M
YoY Change -16.67% -3.7%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $6.600M
YoY Change -100.0% 34.69%
Long-Term Debt Due $924.0K $17.00M
YoY Change -94.56% -43.14%
Total Short-Term Liabilities $19.68M $47.40M
YoY Change -58.48% -7.24%
LONG-TERM LIABILITIES
Long-Term Debt $17.69M $6.300M
YoY Change 180.76% 186.36%
Other Long-Term Liabilities $796.0K $4.500M
YoY Change -82.31% 0.0%
Total Long-Term Liabilities $20.70M $10.80M
YoY Change 91.66% 61.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $19.68M $47.40M
Total Long-Term Liabilities $20.70M $10.80M
Total Liabilities $40.38M $58.40M
YoY Change -30.85% -2.5%
SHAREHOLDERS EQUITY
Retained Earnings $13.87M
YoY Change
Common Stock $4.722M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $31.50M $24.40M
YoY Change
Total Liabilities & Shareholders Equity $71.86M $82.80M
YoY Change -13.21% -14.73%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income -$186.0K -$1.543M
YoY Change -87.95% 397.74%
Depreciation, Depletion And Amortization $1.022M $1.130M
YoY Change -9.56% -21.53%
Cash From Operating Activities -$4.470M $360.0K
YoY Change -1341.67% -132.43%
INVESTING ACTIVITIES
Capital Expenditures $1.029M -$210.0K
YoY Change -590.0% -82.93%
Acquisitions
YoY Change
Other Investing Activities $110.0K -$10.00K
YoY Change -1200.0% -75.0%
Cash From Investing Activities -$910.0K -$220.0K
YoY Change 313.64% -82.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 210.0K 210.0K
YoY Change 0.0% -88.95%
NET CHANGE
Cash From Operating Activities -4.470M 360.0K
Cash From Investing Activities -910.0K -220.0K
Cash From Financing Activities 210.0K 210.0K
Net Change In Cash -5.170M 350.0K
YoY Change -1577.14% -172.92%
FREE CASH FLOW
Cash From Operating Activities -$4.470M $360.0K
Capital Expenditures $1.029M -$210.0K
Free Cash Flow -$5.499M $570.0K
YoY Change -1064.74% 375.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
9443408 shares
CY2012Q4 us-gaap Business Acquisition Purchase Price Allocation Assets Acquired
BusinessAcquisitionPurchasePriceAllocationAssetsAcquired
1500000
CY2007Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
24.74 acre
CY2012Q1 us-gaap Segment Reporting Information Net Assets
SegmentReportingInformationNetAssets
82755000
CY2012Q1 ssy Cash And Cash Equivalent At Carrying Value
CashAndCashEquivalentAtCarryingValue
879000
CY2012Q1 ssy Impairment Of Goodwill
ImpairmentOfGoodwill
931000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10446000
CY2013Q1 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
4041000
CY2013Q1 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2013Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
31479000
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3986000
CY2013Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11000
CY2013Q1 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-497000
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
19682000
CY2013Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3948000
CY2013Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
18612000
CY2013Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5257000
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
13868000
CY2013Q1 us-gaap Assets
Assets
71860000
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2559000
CY2013Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
23755000
CY2013Q1 us-gaap Escrow Deposit
EscrowDeposit
635000
CY2013Q1 us-gaap Inventory Net
InventoryNet
3842000
CY2013Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
603000
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
10031000
CY2013Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63749000
CY2013Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
10211000
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1721000
CY2012Q2 us-gaap Preferred Stock Share Subscriptions
PreferredStockShareSubscriptions
2000000 shares
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71860000
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9443000 shares
CY2013Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
0
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
4722000
CY2013Q1 us-gaap Goodwill
Goodwill
461000
CY2013Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2503000
CY2013Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
0
CY2013Q1 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
9435000
CY2013Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
20699000
CY2013Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
585000
CY2013Q1 us-gaap Long Term Debt
LongTermDebt
0
CY2013Q1 us-gaap Capital Lease Obligations
CapitalLeaseObligations
111000
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3212000
CY2013Q1 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6170000
CY2013Q1 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
281000
CY2013Q1 us-gaap Segment Reporting Information Net Assets
SegmentReportingInformationNetAssets
71698000
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30477000
CY2013Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
924000
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9443000 shares
CY2013Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
13724000
CY2013Q1 us-gaap Assets Current
AssetsCurrent
31948000
CY2013Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13386000
CY2013Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
0
CY2013Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33272000
CY2013Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
17688000
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
796000
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
6409000
CY2013Q1 ssy Net Operating Loss Carry Forwards
NetOperatingLossCarryForwards
2418000
CY2013Q1 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
2215000
CY2013Q1 ssy Cash And Cash Equivalent At Carrying Value
CashAndCashEquivalentAtCarryingValue
2559000
CY2013Q1 ssy Net Current Assets Of Subsidiary
NetCurrentAssetsOfSubsidiary
0
CY2013Q1 ssy Net Noncurrent Assets Of Subsidiary
NetNoncurrentAssetsOfSubsidiary
0
CY2013Q1 ssy Incentive Reimbursement Assets Current
IncentiveReimbursementAssetsCurrent
485000
CY2013Q1 ssy Amount Of Installment
AmountOfInstallment
150000
CY2013Q1 ssy Impairment Of Goodwill
ImpairmentOfGoodwill
0
CY2010Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
71000
CY2011Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
37000
CY2011Q2 ssy Cash And Cash Equivalent At Carrying Value
CashAndCashEquivalentAtCarryingValue
7250000
CY2011Q3 us-gaap Share Price
SharePrice
1.90
CY2011Q3 ssy Pre Payment On Credit Facility Term Loan
PrePaymentOnCreditFacilityTermLoan
8000000
CY2012Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
5891000
CY2012Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
18067000
CY2012Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
29291000
CY2012Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4584000
CY2012Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
19000
CY2012Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-497000
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
31814000
CY2012Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4231000
CY2012Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
23090000
CY2012Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
11543000
CY2012Q2 us-gaap Assets
Assets
79172000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2057000
CY2012Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
22349000
CY2012Q2 us-gaap Escrow Deposit
EscrowDeposit
0
CY2012Q2 us-gaap Inventory Net
InventoryNet
3884000
CY2012Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2012Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9121000
CY2012Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
63856000
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
894000
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79172000
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9447000 shares
CY2012Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Noncurrent
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent
229000
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
4724000
CY2012Q2 us-gaap Goodwill
Goodwill
461000
CY2012Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2566000
CY2012Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
2449000
CY2012Q2 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
18472000
CY2012Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
198000
CY2012Q2 us-gaap Long Term Debt
LongTermDebt
16086000
CY2012Q2 us-gaap Capital Lease Obligations
CapitalLeaseObligations
176000
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3320000
CY2012Q2 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
5174000
CY2012Q2 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
644000
CY2012Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30082000
CY2012Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
9350000
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9447000 shares
CY2012Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
13228000
CY2012Q2 us-gaap Assets Current
AssetsCurrent
30618000
CY2012Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
13521000
CY2012Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
5931000
CY2012Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33774000
CY2012Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13740000
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
907000
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
6934000
CY2012Q2 ssy Professional Liability Risks Non Current
ProfessionalLiabilityRisksNonCurrent
3191000
CY2012Q2 ssy Cash And Cash Equivalent At Carrying Value
CashAndCashEquivalentAtCarryingValue
2057000
CY2012Q2 ssy Net Current Assets Of Subsidiary
NetCurrentAssetsOfSubsidiary
1846000
CY2012Q2 ssy Net Noncurrent Assets Of Subsidiary
NetNoncurrentAssetsOfSubsidiary
7906000
CY2012Q2 ssy Incentive Reimbursement Assets Current
IncentiveReimbursementAssetsCurrent
0
us-gaap Proceeds From Divestiture Of Businesses
ProceedsFromDivestitureOfBusinesses
9800000
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
7400000
ssy Number Of Beds Sold
NumberOfBedsSold
50 Beds
ssy Proceeds From Sale Of Business Unit Used To Pay Term Loan
ProceedsFromSaleOfBusinessUnitUsedToPayTermLoan
5200000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-03-31
dei Entity Central Index Key
EntityCentralIndexKey
0000096793
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Trading Symbol
TradingSymbol
SSY
dei Entity Registrant Name
EntityRegistrantName
SUNLINK HEALTH SYSTEMS INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2995000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-5931000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
17176000
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.59
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
9618000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15440000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9446000 shares
us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
-8359000
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.59
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
5539000
us-gaap Interest Paid
InterestPaid
1485000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
386000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
502000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-290000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3733000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
529000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.25
us-gaap Nature Of Operations
NatureOfOperations
<div> <p style="MARGIN-TOP: 18px; TEXT-INDENT: -8%; MARGIN-BOTTOM: 0px; MARGIN-LEFT: 8%"> <font style="FONT-FAMILY: Times New Roman" size="2"><b>Note 2. &#x2013; Business Operations</b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><u>Business Operations</u></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">SunLink Health Systems, Inc. subsidiaries provide healthcare services in certain rural and exurban markets in the United States. SunLink&#x2019;s business is composed of the ownership of subsidiaries which operate two business segments:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Healthcare Facilities, which consist of</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Our four community hospitals which have a total of 232 licensed beds;</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Our two nursing homes, which have a total of 166 licensed beds, each of which is located adjacent to a corresponding SunLink community hospital; and</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">One hospital facility and related equipment formerly leased to a third party hospital operator.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1">&#xA0;</font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Specialty Pharmacy, which consists of</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Specialty pharmacy services;</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Durable medical equipment;</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Institutional pharmacy services; and</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px"> &#xA0;</p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1">&#xA0;</font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">&#x2022;</font></td> <td valign="top" width="1%"><font size="1">&#xA0;</font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Retail pharmacy products and services, all of which are conducted in rural markets.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">SunLink subsidiaries have conducted the healthcare facilities business since 2001 and the specialty pharmacy business since April 2008. The Specialty Pharmacy Segment currently is operated through Carmichael&#x2019;s Cashway Pharmacy, Inc. (&#x201C;Carmichael&#x201D;), a subsidiary of SunLink ScriptsRx, LLC subsidiary, and is composed of a specialty pharmacy business acquired in April 2008 with four service lines.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">SunLink&#x2019;s Board and management have determined to focus the Company&#x2019;s strategic investments on enhancing the existing hospital portfolio, including the selective disposal of underperforming and non-strategic subsidiaries. The Company believes certain of its four remaining hospital facilities (exclusive of its specialty pharmacy business) are presently underperforming and currently is evaluating the possible sale of one or more of these hospital facilities. There is no assurance any sale will occur or that, if a sale occurs, it will be at a price that results in a gain or net proceeds after transaction costs, taxes and outstanding debt. The Company expects to use a portion of the net proceeds, if any, from future asset sales to fund its working capital needs and for other corporate purposes.</font></p> <p style="MARGIN-TOP: 12px; MARGIN-BOTTOM: 0px; FONT-SIZE: 1px"> &#xA0;</p> <p style="MARGIN-TOP: 0px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On February&#xA0;5, 2013, the Company announced the commencement of a tender offer to purchase at the price of $1.50 per share in cash all of its common shares held by holders of 99 or fewer shares (&#x201C;odd lots&#x201D;) who owned such shares as of the close of business on January&#xA0;31, 2013 (&#x201C;Odd Lot Tender Offer&#x201D;). In addition to the $1.50 per share price, the Company offered each eligible tendering holder a bonus of $100 upon completion of the Odd Lot Tender Offer for the tender of all shares&#xA0;beneficially owned by such holder which were received&#xA0;and not withdrawn prior to the date of expiration of the Odd Lot Tender Offer, which was March&#xA0;26, 2013. In accordance with the terms and conditions of the Offer, SunLink accepted for purchase a total of 2,631 common shares of SunLink tendered by 68 holders pursuant to the Offer. As a result of the completion of the Offer, immediately following payment for the tendered shares, the Company has approximately 9,443,334 common shares issued and outstanding and held by approximately 480 stockholders of record. The shares repurchased were retired immediately. The aggregate cash cost of the Odd Lot Tender Offer was $195 and was recorded in equity. Included in the cash cost are purchase price for the odd lot shares of $4, aggregate bonus payments of $7 and fees and expenses of $184.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">The primary purpose of the Odd Lot Tender Offer was to reduce the number of holders of record of the Company&#x2019;s common shares in order to permit the Company to deregister the common shares with the SEC. The Company&#x2019;s Board and management each believes that deregistering the Company&#x2019;s common shares will result in significant cost savings. Since the Offer failed to accomplish the objective of reducing the number of record holders to fewer than 300, SunLink anticipates that it will take further actions to reduce the number of holders of record of the Company&#x2019;s common shares in order to permit the Company to deregister the common shares with the SEC. As previously disclosed in the Company&#x2019;s offer to purchase, the Board will likely consider other alternatives to achieve that result, including a further tender offer, a reverse stock split or cash out merger (in which a new corporation is formed to merge with the Company and holders of a limited number of Company shares are cashed out), so long as the Board continues to believe that deregistration remains in the Company&#x2019;s best interests.</font></p> </div>
us-gaap Cost Of Goods Sold
CostOfGoodsSold
18085000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
11299000
us-gaap Net Income Loss
NetIncomeLoss
2325000
us-gaap Other Expenses
OtherExpenses
931000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3214000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.25
us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
8000
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
182000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9446000 shares
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10591000
us-gaap Cost Of Services
CostOfServices
5629000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2325000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
9831000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1735000
us-gaap Supplies Expense
SuppliesExpense
6913000
us-gaap Revenues
Revenues
91663000
us-gaap Pension Contributions
PensionContributions
43000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2025000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
635000
us-gaap Sales Revenue Net
SalesRevenueNet
82780000
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
796000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
789000
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
30000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.34
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
108000
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
9269000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2116000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
81000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
76000
ssy Defined Benefit Plan Net Periodic Benefit Costs
DefinedBenefitPlanNetPeriodicBenefitCosts
102000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5239000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1454000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
39894000
us-gaap Interest Expense
InterestExpense
1507000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4347000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
51000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.34
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
188000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
12698000
ssy Discontinued Operation Income Tax Expense Benefit
DiscontinuedOperationIncomeTaxExpenseBenefit
4608000
ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
2164000
ssy Payments To Acquire Property Plant And Equipment Discontinued Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations
41000
ssy Net Revenue Related To Settlements And Filings Of Prior Year Reports
NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports
176000
ssy Number Of Physicians Under Guarantee Agreements
NumberOfPhysiciansUnderGuaranteeAgreements
1 Physician
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3349000
ssy Provision For Doubtful Accounts And Sales Return
ProvisionForDoubtfulAccountsAndSalesReturn
8883000
ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
96000
ssy Assets Acquired Under Capital Lease Obligation Discontinued Operations
AssetsAcquiredUnderCapitalLeaseObligationDiscontinuedOperations
0
ssy Loan Proceeds To Be Used To Finance Improvements
LoanProceedsToBeUsedToFinanceImprovements
1000000
ssy Noncash Assets Acquired Under Capital Lease Obligation Continuing Operations
NoncashAssetsAcquiredUnderCapitalLeaseObligationContinuingOperations
0
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1331000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
12656000
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.08
us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-735000
us-gaap Investment Income Interest
InvestmentIncomeInterest
10000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9317000 shares
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.08
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
791000
us-gaap Interest Paid
InterestPaid
3393000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
510000
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
28000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6371000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-371000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3622000
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
1269000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
us-gaap Cost Of Goods Sold
CostOfGoodsSold
21159000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
11934000
us-gaap Net Income Loss
NetIncomeLoss
-4033000
us-gaap Other Expenses
OtherExpenses
1272000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-4824000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
396000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9317000 shares
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4980000
us-gaap Cost Of Services
CostOfServices
5884000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4033000
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
26184000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-1822000
us-gaap Supplies Expense
SuppliesExpense
6417000
us-gaap Revenues
Revenues
94274000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2193000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2345000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
0
us-gaap Sales Revenue Net
SalesRevenueNet
86556000
us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
743000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
20000
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.52
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
85000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-2514000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7017000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1653000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
39613000
us-gaap Interest Expense
InterestExpense
3405000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-656000
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
36000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.52
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
126000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4000000
ssy Discontinued Operation Income Tax Expense Benefit
DiscontinuedOperationIncomeTaxExpenseBenefit
478000
ssy Defined Benefit Plan Net Periodic Benefit Costs
DefinedBenefitPlanNetPeriodicBenefitCosts
44000
ssy Noncash Assets Acquired Under Capital Lease Obligation Continuing Operations
NoncashAssetsAcquiredUnderCapitalLeaseObligationContinuingOperations
80000
ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
617000
ssy Payments To Acquire Property Plant And Equipment Discontinued Operations
PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations
118000
ssy Provision For Doubtful Accounts And Sales Return
ProvisionForDoubtfulAccountsAndSalesReturn
7718000
ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
311000
ssy Assets Acquired Under Capital Lease Obligation Discontinued Operations
AssetsAcquiredUnderCapitalLeaseObligationDiscontinuedOperations
316000
ssy Net Revenue Related To Settlements And Filings Of Prior Year Reports
NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports
547000
us-gaap Line Of Credit Facility Initiation Date1
LineOfCreditFacilityInitiationDate1
2008-04-23
CY2011Q3 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2500000
CY2011Q3 ssy Share Issued Under Private Placement
ShareIssuedUnderPrivatePlacement
1329000 shares
CY2012Q4 ssy Business Acquisition Date Of Acquiree Purchase Option Agreement
BusinessAcquisitionDateOfAcquireePurchaseOptionAgreement
90 days
CY2011 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
34000
CY2012 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
18000
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1022000
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2013Q1 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
65000
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9446000 shares
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Charge Offs
AllowanceForDoubtfulAccountsReceivableChargeOffs
-3410000
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2013Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
11000
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
129000
CY2013Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
-2000
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-268000
CY2013Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-44000
CY2013Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
7319000
CY2013Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3218000
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-186000
CY2013Q1 us-gaap Other Expenses
OtherExpenses
-93000
CY2013Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-197000
CY2013Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9446000 shares
CY2013Q1 us-gaap Cost Of Services
CostOfServices
1777000
CY2013Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-186000
CY2013Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
318000
CY2013Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-369000
CY2013Q1 us-gaap Supplies Expense
SuppliesExpense
2213000
CY2013Q1 us-gaap Revenues
Revenues
32106000
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-371000
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
29240000
CY2013Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
268000
CY2013Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2013Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
10000
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.02
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
36000
CY2013Q1 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2995000
CY2013Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
27000
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
24000
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-568000
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8418000
CY2012Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
3823000
CY2012Q1 us-gaap Other Expenses
OtherExpenses
0
CY2012Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1684000
CY2012Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2012Q1 us-gaap Net Income Loss
NetIncomeLoss
-1543000
CY2012Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
450000
CY2013Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13287000
CY2013Q1 us-gaap Interest Expense
InterestExpense
301000
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2013Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
17000
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.02
CY2013Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
CY2013Q1 ssy Discontinued Operation Income Tax Expense Benefit
DiscontinuedOperationIncomeTaxExpenseBenefit
10000
CY2013Q1 ssy Defined Benefit Plan Net Periodic Benefit Costs
DefinedBenefitPlanNetPeriodicBenefitCosts
34000
CY2013Q1 ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
1029000
CY2013Q1 ssy Provision For Doubtful Accounts And Sales Return
ProvisionForDoubtfulAccountsAndSalesReturn
2866000
CY2013Q1 ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
45000
CY2013Q1 ssy Financing Costs And Expenses
FinancingCostsAndExpenses
2710000
CY2013Q1 ssy Net Revenue Related To Settlements And Filings Of Prior Year Reports
NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports
176000
CY2012Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
931000
CY2012Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1130000
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.01
CY2012Q1 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
0
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9448000 shares
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.01
CY2012Q1 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
141000
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
201000
CY2012Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1054000
CY2012Q1 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
210000
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9448000 shares
CY2012Q1 us-gaap Cost Of Services
CostOfServices
1961000
CY2012Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1543000
CY2012Q1 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
8912000
CY2012Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-434000
CY2012Q1 us-gaap Supplies Expense
SuppliesExpense
2157000
CY2012Q1 us-gaap Revenues
Revenues
33317000
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-433000
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
31354000
CY2012Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
239000
CY2012Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2012Q1 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
10000
CY2012Q1 ssy Expenses On Physician Guarantees And Recruitment
ExpensesOnPhysicianGuaranteesAndRecruitment
57000
CY2012Q1 ssy Net Revenue Related To Settlements And Filings Of Prior Year Reports
NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports
496000
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.18
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
42000
CY2012Q1 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
14000
CY2012Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
29000
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2117000
CY2012Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
526000
CY2012Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
13261000
CY2012Q1 us-gaap Interest Expense
InterestExpense
1071000
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0
CY2012Q1 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
18000
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.18
CY2012Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
42000
CY2012Q1 ssy Discontinued Operation Income Tax Expense Benefit
DiscontinuedOperationIncomeTaxExpenseBenefit
69000
CY2012Q1 ssy Defined Benefit Plan Net Periodic Benefit Costs
DefinedBenefitPlanNetPeriodicBenefitCosts
22000
CY2012Q1 ssy Payments To Acquire Property Plant And Equipment Continuing Operations
PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations
204000
CY2012Q1 ssy Provision For Doubtful Accounts And Sales Return
ProvisionForDoubtfulAccountsAndSalesReturn
1963000

Files In Submission

Name View Source Status
0001193125-13-222641-index-headers.html Edgar Link pending
0001193125-13-222641-index.html Edgar Link pending
0001193125-13-222641.txt Edgar Link pending
0001193125-13-222641-xbrl.zip Edgar Link pending
d501344d10q.htm Edgar Link pending
d501344dex1029.htm Edgar Link pending
d501344dex1030.htm Edgar Link pending
d501344dex311.htm Edgar Link pending
d501344dex312.htm Edgar Link pending
d501344dex321.htm Edgar Link pending
d501344dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssy-20130331.xml Edgar Link completed
ssy-20130331.xsd Edgar Link pending
ssy-20130331_cal.xml Edgar Link unprocessable
ssy-20130331_def.xml Edgar Link unprocessable
ssy-20130331_lab.xml Edgar Link unprocessable
ssy-20130331_pre.xml Edgar Link unprocessable